Alphatec Shares Plummet After Full-Year Revenue Outlook Is Cut

Dow Jones05-07

By Chris Kuo

 

Alphatec Holdings shares plummeted after the company lowered its full-year revenue outlook.

Shares of the medical technology company dropped 32% to $6.97. The shares plunged to a new 52-week low of $6.85 on Wednesday.

On Tuesday afternoon, Alphatec lowered its full-year revenue outlook amid declining sales of its EOS imaging systems. It now expects full-year revenue of about $882 million, compared with previous guidance for about $890 million.

Alphatec narrowed its first-quarter loss to $33.9 million, or 22 cents a share, from a loss of $51.9 million, or 35 cents a share, a year earlier. Analysts polled by FactSet expected a loss of 19 cents a share.

Revenue rose to $192.1 million from $169.2 million a year earlier. Analysts were expecting revenue of $197.5 million.

Sales of the company's EOS imaging systems were $14 million in the quarter, down $3 million year-over-year, Chief Financial Officer J. Todd Koning said in an earnings call. Revenue per case declined about 3% year over year, Koning said.

 

(END) Dow Jones Newswires

May 06, 2026 13:02 ET (17:02 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment